C. Buysse

Immunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesothelium

E. van Marck, W. Jacobs, M. Ramael, 1992, The Journal of pathology.

Immunoreactivity for p‐170 glycoprotein in malignant mesothelioma and in non‐neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB‐1

E. van Marck, J. V. van Meerbeeck, K. Segers, 1992, The Journal of pathology.

Immunoreactivity for the β chain of the platelet‐derived growth factor receptor in malignant mesothelioma and non‐neoplastic mesothelium

E. van Marck, K. Segers, M. Ramael, 1992, The Journal of pathology.

Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA)

E. van Marck, J. V. van Meerbeeck, J. Weyler, 1994, The Journal of pathology.

Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura.

E. van Marck, J. Van den Bossche, K. Segers, 1995, Histology and histopathology.

Nucleolar organizer regions in mesothelial proliferations

E. van Marck, M. Ramael, J. Bossche, 1992, The Journal of pathology.

Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium

K. Segers, E. Marck, M. Ramael, 2005, Virchows Archiv A.